Literature DB >> 23229770

Misregulation of suppressors of cytokine signaling in eosinophilic esophagitis.

Ma Paz Zafra1, Natally Cancelliere, Pablo Rodríguez del Río, Mónica Ruiz-García, Laura Estévez, Victoria Andregnette, Silvia Sánchez-García, Ana Fiandor, Elena Collantes, Joaquín Sastre, Santiago Quirce, María Dolores Ibáñez, Victoria del Pozo.   

Abstract

BACKGROUND: Several findings suggest that eosinophilic esophagitis (EoE) is strongly associated with atopy and allergen-driven, Th2-type immune responses, indicating the association of EoE with immune dysregulation. The objective of this study is to ascertain the molecular mechanism involved in EoE disease development a Th2 condition.
METHODS: 25 patients with diagnosis of EoE and 17 non-EoE controls were recruited by the gastroenterology and allergy departments from three different hospitals. Transcription analysis of suppressors of cytokine signaling 1, 3, 5 (SOCS), interleukin-5 (IL), IL-13, eotaxin (CCL26), eoataxin receptor (CCR3), and mitogen-activated protein kinase 1 (MAPK1) was performed in esophageal biopsies by real time PCR. Western blot of ERK esophageal protein and additional measures of IL-5 and VEGF levels in serum were performed.
RESULTS: The esophagus of EoE patients expresses and synthesizes high levels of SOCS1 and SOCS3 proteins (P < 0.05), and these expression correlated with levels of IL-5, IL-13, CCL26, CCR3, and MAPK1 genes. In addition, we demonstrate the implication of the ERK pathway (P < 0.001).
CONCLUSIONS: SOCS proteins probably contribute to EoE pathogenesis by directly or indirectly inducing the Th2 profile, as well as by promoting the production of Th2 cytokines. All these findings further enhance our understanding of the mechanism of EoE, and accumulating evidence suggests that EoE pathogenesis is likely to be due to misregulation of immunological pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229770     DOI: 10.1007/s00535-012-0723-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  37 in total

Review 1.  Suppressors of cytokine signaling and immunity.

Authors:  Masato Kubo; Toshikatsu Hanada; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2003-12       Impact factor: 25.606

2.  Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells.

Authors:  William A Sands; Hayley D Woolson; Gillian R Milne; Claire Rutherford; Timothy M Palmer
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  A striking local esophageal cytokine expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Beatriz Rodriguez-Jimenez; Karen Burwinkel; Margaret H Collins; Annette Ahrens; Eileen S Alexander; Bridget K Buckmeier Butz; Sean C Jameson; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Philip E Putnam; J Pablo Abonia; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

Review 4.  Chemokines in asthma: cooperative interaction between chemokines and IL-13.

Authors:  Nives Zimmermann; Gurjit Khurana Hershey; Paul S Foster; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

5.  Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.

Authors:  Sandeep K Gupta; Joseph F Fitzgerald; Tamara Kondratyuk; Harm HogenEsch
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-01       Impact factor: 2.839

Review 6.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

Review 7.  SOCS regulation of the JAK/STAT signalling pathway.

Authors:  Ben A Croker; Hiu Kiu; Sandra E Nicholson
Journal:  Semin Cell Dev Biol       Date:  2008-07-30       Impact factor: 7.727

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

Review 9.  Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.

Authors:  Ioannis D Dimitriou; Liliana Clemenza; Andrew J Scotter; Grace Chen; Fiona M Guerra; Robert Rottapel
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  Suppressors of cytokine signaling 3 expression in eosinophils: regulation by PGE₂ and Th2 cytokines.

Authors:  Esther López; María Paz Zafra; Beatriz Sastre; Cristina Gámez; Mar Fernández-Nieto; Joaquín Sastre; Carlos Lahoz; Santiago Quirce; Victoria Del Pozo
Journal:  Clin Dev Immunol       Date:  2011-04-27
View more
  6 in total

Review 1.  Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.

Authors:  Swathi Eluri; Evan S Dellon
Journal:  Curr Opin Gastroenterol       Date:  2015-07       Impact factor: 3.287

Review 2.  Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?

Authors:  William Munday; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 3.  Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications.

Authors:  Carlo Maria Rossi; Marco Vincenzo Lenti; Stefania Merli; Amelia Licari; Martina Votto; Gian Luigi Marseglia; Antonio Di Sabatino
Journal:  Clin Transl Allergy       Date:  2022-05-23       Impact factor: 5.657

4.  Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review.

Authors:  Brittany T Hines; Matthew A Rank; Benjamin L Wright; Lisa A Marks; John B Hagan; Alex Straumann; Matthew Greenhawt; Evan S Dellon
Journal:  Ann Allergy Asthma Immunol       Date:  2018-05-16       Impact factor: 6.347

5.  Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis.

Authors:  Hiroki Sato; Nao Nakajima; Kazuya Takahashi; Go Hasegawa; Ken-Ichi Mizuno; Satoru Hashimoto; Satoshi Ikarashi; Kazunao Hayashi; Yutaka Honda; Junji Yokoyama; Yuichi Sato; Shuji Terai
Journal:  World J Gastroenterol       Date:  2017-04-07       Impact factor: 5.742

6.  Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions.

Authors:  Katarzyna Magierowska; Dominik Bakalarz; Dagmara Wójcik; Edyta Korbut; Aleksandra Danielak; Urszula Głowacka; Robert Pajdo; Grzegorz Buszewicz; Grzegorz Ginter; Marcin Surmiak; Sławomir Kwiecień; Anna Chmura; Marcin Magierowski; Tomasz Brzozowski
Journal:  Cells       Date:  2020-05-12       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.